Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,710 | 236 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,601 | 106 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $619.45 | 44 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $351.67 | 23 | $0 (2024) |
| QOL Medical, LLC | $301.70 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $247.39 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $146.73 | 5 | $0 (2024) |
| Shire North American Group Inc | $59.43 | 4 | $0 (2019) |
| Lilly USA, LLC | $55.92 | 3 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $51.66 | 2 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $44.03 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $981.30 | 49 | ABBVIE INC. ($201.07) |
| 2023 | $646.27 | 35 | AbbVie Inc. ($177.05) |
| 2022 | $360.90 | 22 | ABBVIE INC. ($172.82) |
| 2021 | $607.12 | 40 | AbbVie Inc. ($436.81) |
| 2020 | $230.07 | 17 | AbbVie Inc. ($159.66) |
| 2019 | $478.16 | 38 | AbbVie, Inc. ($299.23) |
| 2018 | $234.61 | 21 | Janssen Biotech, Inc. ($115.08) |
| 2017 | $171.53 | 14 | AbbVie, Inc. ($104.14) |
All Payment Transactions
236 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $28.84 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Immunology | ||||||
| 08/27/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: ONCOLOGY | ||||||
| 08/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/07/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: Immunology | ||||||
| 07/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Immunology | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Gastroenterology | ||||||
| 07/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/13/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Immunology | ||||||
| 06/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 201 | 201 | $216,463 | $19,803 |
| 2022 | 4 | 232 | 233 | $277,022 | $25,094 |
| 2021 | 4 | 223 | 223 | $267,749 | $24,908 |
| 2020 | 4 | 278 | 280 | $332,175 | $32,407 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 65 | 65 | $70,958 | $5,944 | 8.4% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 55 | 55 | $53,303 | $5,297 | 9.9% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 41 | 41 | $50,367 | $4,786 | 9.5% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 40 | 40 | $41,836 | $3,775 | 9.0% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 86 | 86 | $103,979 | $8,407 | 8.1% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 50 | 50 | $65,357 | $6,223 | 9.5% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 55 | 56 | $61,182 | $6,191 | 10.1% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 41 | 41 | $46,505 | $4,274 | 9.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 87 | 87 | $107,687 | $8,920 | 8.3% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 68 | 68 | $74,778 | $7,433 | 9.9% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 45 | 45 | $58,865 | $6,082 | 10.3% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 23 | 23 | $26,420 | $2,473 | 9.4% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 106 | 108 | $129,162 | $11,410 | 8.8% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 91 | 91 | $100,580 | $10,517 | 10.5% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 47 | 47 | $63,345 | $6,723 | 10.6% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 34 | 34 | $39,089 | $3,756 | 9.6% |
About Dr. Ryan Zollett, D.O
Dr. Ryan Zollett, D.O is a Anesthesiology healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1790904019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Zollett, D.O has received a total of $3,710 in payments from pharmaceutical and medical device companies, with $981.30 received in 2024. These payments were reported across 236 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,710).
As a Medicare-enrolled provider, Zollett has provided services to 934 Medicare beneficiaries, totaling 937 services with total Medicare billing of $102,212. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Dayton, OH
- Active Since 04/25/2007
- Last Updated 05/15/2015
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1790904019
Products in Payments
- CREON (Drug) $462.54
- XIFAXAN (Drug) $307.73
- HUMIRA (Biological) $304.09
- TRULANCE (Drug) $275.84
- STELARA (Biological) $206.00
- Humira (Biological) $191.65
- ENTYVIO (Biological) $187.08
- RINVOQ (Biological) $182.94
- SUCRAID (Drug) $169.86
- DUPIXENT (Biological) $146.73
- Creon (Drug) $144.33
- Sucraid (Drug) $131.84
- GATTEX (Drug) $131.00
- Mavyret (Drug) $103.53
- MAVYRET (Drug) $97.12
- OMVOH (Drug) $55.92
- LINZESS (Drug) $55.07
- VOQUEZNA (Drug) $51.66
- SKYRIZI (Biological) $45.65
- OCALIVA (Drug) $44.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Dayton
Dr. Tammy Dann, D.o, D.O
Anesthesiology — Payments: $367,727
Dr. David Gooden, Do, DO
Anesthesiology — Payments: $34,092
Dr. Janice Pauley, M.d, M.D
Anesthesiology — Payments: $9,625
Gary Black, M.d, M.D
Anesthesiology — Payments: $9,436
Scott Hadaway, Md, MD
Anesthesiology — Payments: $6,685
Nadeem Ahmed, Md, MD
Anesthesiology — Payments: $5,291